Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review

Saved in:
Bibliographic Details
Published in:Biologics: Targets & Therapy
Format: Online Article RSS Article
Published: 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1868553673936732160
collection WordPress RSS
FRELIP Feed Integration
container_title Biologics: Targets & Therapy
description
discipline_display Biology
discipline_facet Biology
format Online Article
RSS Article
genre Journal Article
id rss_article:81588
institution FRELIP
journal_source_facet Biologics: Targets & Therapy
last_indexed 2026-06-20T21:40:44.254Z
publishDate 2025
publishDateSort 2025
record_format rss_article
spellingShingle Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
Biology
General
Biology
sub_discipline_display General
sub_discipline_facet General
subject_display Biology
General
Biology
subject_facet Biology
General
Biology
title Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_alt Cambio de formulación intravenosa a subcutánea de tocilizumab en artritis reumatoide: análisis de cohorte retrospectivo y revisión sistemática de la literatura
Passage de la formulation intraveineuse à sous-cutanée du tocilizumab dans la polyarthrite rhumatoïde : analyse de cohorte rétrospective et revue systématique de la littérature
Troca da Formulação Intravenosa para Subcutânea de Tocilizumabe na Artrite Reumatoide: Análise de Coorte Retrospectiva e Revisão Sistemática da Literatura
title_auth Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_es_txt Cambio de formulación intravenosa a subcutánea de tocilizumab en artritis reumatoide: análisis de cohorte retrospectivo y revisión sistemática de la literatura
title_fr_txt Passage de la formulation intraveineuse à sous-cutanée du tocilizumab dans la polyarthrite rhumatoïde : analyse de cohorte rétrospective et revue systématique de la littérature
title_full Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_fullStr Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_full_unstemmed Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_pt_txt Troca da Formulação Intravenosa para Subcutânea de Tocilizumabe na Artrite Reumatoide: Análise de Coorte Retrospectiva e Revisão Sistemática da Literatura
title_short Switch from Intravenous to Subcutaneous Formulation of Tocilizumab in Rheumatoid Arthritis: Retrospective Cohort Analysis and Systematic Literature Review
title_sort switch from intravenous to subcutaneous formulation of tocilizumab in rheumatoid arthritis: retrospective cohort analysis and systematic literature review
topic Biology
General
Biology
url https://www.dovepress.com/switch-from-intravenous-to-subcutaneous-formulation-of-tocilizumab-in--peer-reviewed-fulltext-article-BTT